Coronary heart disease, unstable angina, PTCA: New indications for low molecular weight heparins?

Thrombosis Research

Volumn 81, Issue 2 SUPPL., 1996, Pages

  Breddin, Hans K ^a  

^a Intl Inst Thromb/Vasc Dis eV   (Germany)

Author keywords

Angina; Antithrombotic agents; Aspirin; Heparin; Low molecular weight heparins; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANGINA PECTORIS; CONFERENCE PAPER; HEART INFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; RESTENOSIS; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0029865806     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(95)00229-4     Document Type: Conference Paper

References (21)

1. THÉROUX, P., WATERS, D., LAM, J. JUNEAU, M. and McCANS, J. Reactivation of unstable angina after the discontinuation of heparin. New Engl J Med 327, 141-145, 1992.
2. GRANGER, C.P., MILLER, J.M., BOVILL, E.G., GRUBER, A., TRACY, R.P., KRUCOFF, M.W., GREEN, C., BERRIOS,E., HARRINGTON, R.A., OHMAN, E.M. and CALIFF, R.M. Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes. Circulation 91, 1929-1935, 1995.
3. COLOMBO, A., HALL, P., NAKAMURA, S. ALMAGOR, Y., MAIELLO, L., MARTINI, G., GAGLIONE, A., GOLDBERG, S.L. and TOBIS, J.M. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 91, 1676-1688, 1995.
4. BARRAGAN, P., SAINSOUS, J., SILVESTRI, M., BOUVIER, J.L., COMET, B. SIMÉONI, J.B., CHARMASSON, C. and BREMONDY, M. Ticlopidine and subcutaneous heparin as an alternative regimen following coronary stenting. Catheter Cardiovasc Diagn 32, 133-138 1994.
5. THÉROUX, P., QUIMET, H., McGANS, J., LATOUR, J.G., JOLY, P., LÉVY, G., PELLETIER, E. JUNEAU, M., STASIAK, J., DEGUISE, P., PELLETIER, G.B., RINZLER, D. and WATERS, D.D. Aspirin, heparin or both to treat unstable angina. New Engl J Med 336, 1105-1111 1988.
6. LEWIS, H.D., DAVIES, J.W., ARCHIBALD, D.G., STEINKE, W.E. SMITHERMAN, T.C., DOHERTY, J.E., SCHNAPER H.W., LEWINTER, M.M., LINARES, E. POUGET, J.M., SABHARWAL, S.C., CHESLER, E. and DEMOTS, H. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: results of a veterans administration cooperative study. New Engl J Med 309, 396-403 1983.
7. CAIRNS, J.A., GENT, M., SINGER, J. FINNIE, K.J. FROGGATT, G.M. HOLDER, D.A., JABLONSKY, G., KOSTUCK, W.J., MELENDEZ, L.J., MYERS, M.G., SACKETT, D.L., SEALEY, B.J. and TANSER, P.H. Aspirin, sulphinpyrazone or both in unstable angina: Results of a Canadian multicenter trial. New Engl J Med 313, 1369-1375, 1985.
8. NERI SERNERI, G.G., MODESTI, P.A., GENSINI, G.F., BRANZI, A., MELANDRI, G., POGGESI, L., ROSTAGNO, C., TAMBURINI, C., CARNOVALI, M., and MAGNANI, B. Randomized comparison of subcutaneous heparin, intravenous heparin and aspirin in unstable angina. Lancet 345, 1201-1204, 1995.
9. Cooperative Unstable Angina Study Group: Unstable angina pectoris: National cooperative study group to compare surgical and medical therapy. II In hospital experience and initial follow-up results in patients with one, two and three vessel disease. Am J Cardiol 42, 839-848, 1978.
10. Cooperative Unstable Angina Study Group: Unstable angina pectoris: National cooperative study group to compare surgical and medical therapy. III. Results in patients with 5-t segment elevation during pain. Am J Cardiol 45, 819-824, 1980.
11. MASERI, A., CHIERCHA, S. and ÀBBATE, A. Pathogenetic mechanism underlying the clinical events associated with atherosclerotic heart disease. Circulation 62, (6pt2) V3-V13, 1989.
12. RAFFLENBEUL, W., RUSSEL, R.O. and LICHTLEN, P.R. Angiographic anatomy of coronary arteries in unstable angina. In: Unstable Angina Pectoris W. Rafflenbeul, P.R. Lichtlen and R. Balcon (eds.), pp. 51-57, Thieme, Stuttgart (1981).
13. MOISE, A., THÉROUX, P., TAEYMANS, Y., DESCOINGS, B., LESPÉRANCE, J., WATERS, D.D., PELLETIER, G.B. and BOURASSA, M.G. Unstable angina and progression of coronary atherosclerosis. New Engl J Med 309, 685-689, 1983.
14. AMBROSE, J.A., WIMBERS, S.L., ARORA, R.R., ENG, A., RICCIO, A., GORLIN, R. and FUSTER, V. Angiographic evolution of coronary artery morphology in unstable angina. J Am Coll Cardiol 7, 472-478, 1986.
15. NERI SERNERI, G.G., GENSINI, G.F., POGGESI, L., TROTTA, F., MODESTI, P.A., BODDI, M., IERI, A., MARGHERI, M., CASOLO, G.C. BINI, M., ROSTAGNO, C., CARNOVAL, M. and ABBATE, R. Effect of heparin, aspirin and Ateplase in reduction of myocardial ischemia in refractory unstable angina. Lancet 335, 615-618, 1990.
16. HOLDRIGHT, D., PATEL, D., CUNNINGHAM, D., THOMAS, R., HUBBARD, W., HENDRY, G., SUTTON, G. and FOX, K. Comparison of the effect of heparin and aspirin versus aspirin alone on transient myocardial ischemia and in-hospital prognosis in patients with unstable angina. J Am Coll Cardiol 24, 39-45, 1994.
17. UEDA, M., BECKER, A.E., FUJIMOTO, T. and TSUKADA, T. The early phenomena of restenosis following percutaneous transluminal coronary angioplasty. Eur Heart J 12, 937-945, 1991.
18. ROSS R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809, 1993.
19. BETZ, E. and SCHLOTE, W. Responses of vessel walls to chronically applied electric stimuli. Basic Res Cardiol 74, 10-20, 1979.
20. PREISACK, M.B. and KARSCH, K.R. Experimental and early clinical experience with reviparin-sodium for prevention of restenosis after percutaneous transluminal coronary angioplasty. Blood Coagul Fibrinolysis (Suppl 1) S55-8, 1993.
21. FAXON, D.P., SPIRO, T.E., MINOR, S., COTÉ, G., DOUGLAS, J., GOTTLIEB, R., CALIFF, R. DOROSTI, K., TOPOL, E., GORDON, J.B. and OHMEN, M. Low molecular weight heparin in prevention of restenosis after angioplasty. Circulation 90, 908-914, 1994.